{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:01:20Z","timestamp":1753876880046,"version":"3.41.2"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000905","name":"Commonwealth Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Researchers and decision-makers use health gain measures to assess the value of health interventions. However, our current understanding of how these measures are understandable and accessible to the community is limited. This study examined a diverse group of stakeholders\u2019 attitudes and preferences for 9 commonly used health gain measures. We recruited 20 stakeholders, including patients, caregivers, pharmacists, allied health professionals, and citizens. We conducted 2 in-person deliberative meetings in which participants learned, discussed, deliberated on, and ranked 9 health gain measures. The final ranking conducted after unified deliberation showed the quality-adjusted life year (QALY) as the top-ranked measure, followed by the clinical benefit rating method used by the U.S. Preventive Services Task Force, and multicriteria decision analysis (MCDA). We identified 3 themes during deliberations: the importance of using patient values in population-based health gain measures, examining complementary measures together, and choosing measures that are intuitive and easy to understand. Future policymaking should consider incorporating the QALY, clinical benefit rating, and MCDA into prioritization decisions.<\/jats:p>","DOI":"10.1093\/haschl\/qxae111","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T06:14:04Z","timestamp":1725862444000},"source":"Crossref","is-referenced-by-count":0,"title":["Public deliberation on health gain measures"],"prefix":"10.1093","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9712-0657","authenticated-orcid":false,"given":"Ching-Hsuan","family":"Lin","sequence":"first","affiliation":[{"name":"Center for the Evaluation of Value and Risk in Health, Tufts Medical Center , 800 Washington St, Boston, MA 02111 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1212-6973","authenticated-orcid":false,"given":"Tara A","family":"Lavelle","sequence":"additional","affiliation":[{"name":"Center for the Evaluation of Value and Risk in Health, Tufts Medical Center , 800 Washington St, Boston, MA 02111 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7287-4668","authenticated-orcid":false,"given":"Marie C","family":"Phillips","sequence":"additional","affiliation":[{"name":"Center for the Evaluation of Value and Risk in Health, Tufts Medical Center , 800 Washington St, Boston, MA 02111 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2593-3547","authenticated-orcid":false,"given":"Abigail G","family":"Riley","sequence":"additional","affiliation":[{"name":"Center for the Evaluation of Value and Risk in Health, Tufts Medical Center , 800 Washington St, Boston, MA 02111 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-8129","authenticated-orcid":false,"given":"Daniel","family":"Ollendorf","sequence":"additional","affiliation":[{"name":"Center for the Evaluation of Value and Risk in Health, Tufts Medical Center , 800 Washington St, Boston, MA 02111 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"issue":"2","key":"2024091917352530500_qxae111-B1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jval.2016.11.027","article-title":"Using cost-effectiveness analysis to address health equity concerns","volume":"20","author":"Cookson","year":"2017","journal-title":"Value Health"},{"author":"Seshamani","key":"2024091917352530500_qxae111-B2"},{"issue":"10","key":"2024091917352530500_qxae111-B3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"2024091917352530500_qxae111-B4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jval.2019.08.003","article-title":"Does the Institute for Clinical and Economic review revise its findings in response to industry comments?","volume":"22","author":"Cohen","year":"2019","journal-title":"Value Health"},{"key":"2024091917352530500_qxae111-B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.socscimed.2015.03.024","article-title":"Effectiveness of public deliberation methods for gathering input on issues in healthcare: results from a randomized trial","volume":"133","author":"Carman","year":"2015","journal-title":"Soc Sci Med"},{"issue":"2","key":"2024091917352530500_qxae111-B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/hast.26","article-title":"What is public deliberation?","volume":"42","author":"Blacksher","year":"2012","journal-title":"Hastings Cent Rep"},{"author":"Carman KL, Heeringa JW, Heil SKR","key":"2024091917352530500_qxae111-B7"},{"key":"2024091917352530500_qxae111-B8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.socscimed.2018.07.004","article-title":"Quantifying life: understanding the history of quality-adjusted life-years (QALYs)","volume":"211","author":"MacKillop","year":"2018","journal-title":"Soc Sci Med"},{"issue":"6","key":"2024091917352530500_qxae111-B9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0167-6296(97)00004-0","article-title":"Understanding DALYs","volume":"16","author":"Murray","year":"1997","journal-title":"J Health Econ"},{"key":"2024091917352530500_qxae111-B10"},{"author":"Lamboley","key":"2024091917352530500_qxae111-B11"},{"issue":"1","key":"2024091917352530500_qxae111-B12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/1331677X.2015.1075139","article-title":"Multiple criteria decision-making techniques and their applications\u2014a review of the literature from 2000 to 2014","volume":"28","author":"Mardani","year":"2015","journal-title":"Econ Res-Ekon Istra\u017eivanja"},{"issue":"4","key":"2024091917352530500_qxae111-B13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jval.2017.10.001","article-title":"The use of MCDA in HTA: great potential, but more effort needed","volume":"21","author":"Marsh","year":"2018","journal-title":"Value Health"},{"issue":"1","key":"2024091917352530500_qxae111-B14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12889-020-08685-7","article-title":"The social value of investing in public health across the life course: a systematic scoping review","volume":"20","author":"Ashton","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"2024091917352530500_qxae111-B15","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.amepre.2017.07.004","article-title":"U.S. Preventive Services Task Force methods to communicate and disseminate clinical preventive services recommendations","volume":"54","author":"Kurth","year":"2018","journal-title":"Am J Prev Med"},{"author":"dp_admin","key":"2024091917352530500_qxae111-B16"},{"author":"Non-Alcoholic Steatohepatitis","key":"2024091917352530500_qxae111-B17"},{"key":"2024091917352530500_qxae111-B18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14737167.2023.2279725","article-title":"Revival? Prospects for a return to comprehensive and coordinated health technology assessment in America","volume":"24","author":"Ollendorf","year":"2024","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2024091917352530500_qxae111-B19"},{"key":"2024091917352530500_qxae111-B20"},{"author":"House Passes QALY Ban Bill","key":"2024091917352530500_qxae111-B21"},{"issue":"9","key":"2024091917352530500_qxae111-B22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1377\/hlthaff.2021.00343","article-title":"Controversy over using quality-adjusted life-years in cost-effectiveness analyses: a systematic literature review: systematic literature review examines the controversy over the use of quality-adjusted life-year in cost-effectiveness analyses","volume":"40","author":"Rand","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"2024091917352530500_qxae111-B23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"key":"2024091917352530500_qxae111-B24"},{"issue":"3","key":"2024091917352530500_qxae111-B25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s41669-020-00250-7","article-title":"National Healthcare Economic Evaluation guidelines: a cross-country comparison","volume":"5","author":"Sharma","year":"2021","journal-title":"PharmacoEconomics\u2014Open"},{"issue":"8","key":"2024091917352530500_qxae111-B26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","article-title":"Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines","volume":"21","author":"Kennedy-Martin","year":"2020","journal-title":"Eur J Health Econ"},{"key":"2024091917352530500_qxae111-B27","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1111\/j.1524-4733.2009.00522.x","article-title":"Toward a consensus on the QALY","volume":"12","author":"Drummond","year":"2009","journal-title":"Value Health"},{"key":"2024091917352530500_qxae111-B28","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780197512883.001.0001","volume-title":"The Right Price: A Value-Based Prescription for Drug Costs","author":"Neumann","year":"2021"},{"issue":"1","key":"2024091917352530500_qxae111-B29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13023-023-02701-w","article-title":"Exploring the feasibility of using the ICER evidence rating matrix for comparative clinical effectiveness in assessing treatment benefit and certainty in the clinical evidence on orphan therapies for paediatric indications","volume":"18","author":"Wex","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2024091917352530500_qxae111-B30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/0272989X211019040","article-title":"The application of multicriteria decision analysis methods in health care: a literature review","volume":"42","author":"Khan","year":"2022","journal-title":"Med Decis Making"},{"issue":"4","key":"2024091917352530500_qxae111-B31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jval.2022.01.010","article-title":"The history and future of the \u201cISPOR value flower\u201d: addressing limitations of conventional cost-effectiveness analysis","volume":"25","author":"Neumann","year":"2022","journal-title":"Value Health"},{"issue":"6","key":"2024091917352530500_qxae111-B32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10198-019-01052-3","article-title":"Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art","volume":"20","author":"Oliveira","year":"2019","journal-title":"Eur J Health Econ"},{"issue":"5","key":"2024091917352530500_qxae111-B33","doi-asserted-by":"publisher","first-page":"e014719","DOI":"10.1136\/bmjopen-2016-014719","article-title":"Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments","volume":"7","author":"Harrison","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"2024091917352530500_qxae111-B34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-0105.141942","article-title":"Qualitative research method-interviewing and observation","volume":"5","author":"Jamshed","year":"2014","journal-title":"J Basic Clin Pharm"}],"container-title":["Health Affairs Scholar"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/advance-article-pdf\/doi\/10.1093\/haschl\/qxae111\/59043466\/qxae111.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/2\/9\/qxae111\/59203945\/qxae111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article-pdf\/2\/9\/qxae111\/59203945\/qxae111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:35:34Z","timestamp":1726767334000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/healthaffairsscholar\/article\/doi\/10.1093\/haschl\/qxae111\/7750929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/haschl\/qxae111","relation":{},"ISSN":["2976-5390"],"issn-type":[{"type":"electronic","value":"2976-5390"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,30]]},"article-number":"qxae111"}}